
Growth in Irish services sector is subdued
AIB
purchasing managers index (PMI) has revealed.
In the aftermath of
US tariffs
policy announcements and volatility in the financial markets, the 12-month outlook was the weakest since October 2020 in the face of the uncertainty.
'Firms in the Irish services sector remained optimistic on the prospects for expansion in activity levels over the coming 12 months,' AIB chief economist David McNamara said, with 38 per cent of participating companies projecting growth against 18 per cent forecasting contraction.
'However, the strength of sentiment continued to soften, falling to its lowest level since October 2020.
READ MORE
'Firms cited the potential impact of US tariffs, financial market turbulence and uncertainty in relation to international trade.'
The seasonally adjusted AIB Ireland services business activity index fell to 52.8 in April, from 55.3 in March, showing that services activity still expanded during the month but at a much slower pace. The index ranges from 0 to 100, with a figure above 50 showing growth.
While growth was slow, job creation in the service sector continued at a 'steady pace', which was above the long-term average.
The growth of new business and total activity increased at the slowest rates in 18 and 15 months respectively. The new businesses index underwent its largest monthly fall since January 2021.
Wages remained the principal driver of cost inflation in April, the AIB survey found, noting that average input prices increased at the weakest rate in five months and at a rate that was 'broadly equal' to the overall trends in the industry.
Other sources of cost inflation mentioned in the survey were insurance, fuel, food and general supplies. Cost pressures eased in multiple sectors including in transport, tourism and leisure. The financial services sector experienced a steeper increase in cost inflation than last month and the largest overall increase.
Despite the reduction in input costs for the transport, tourism and leisure industry, the PMI found that the sector had a decrease in outstanding business for the fourth time in five months, and employment growth was weak. The sector saw a decline for the second month in a row.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Irish Independent
an hour ago
- Irish Independent
EBS and Haven cut some mortgage rates and extend cash-back offers
EBS and Haven, the broker-focused units of AIB, are reducing mortgage rates by up to 0.50 percentage points on some products. It comes the day before European Central Bank (ECB) meeting, where wholesale lending rates are expected to be left on hold. The EBS and Haven cuts are for non-green mortgages and apply to new and existing customers coming off fixed rates or moving from a variable rate with the lenders. Broker Michael Dowling questioned why the EBS and Haven 'green rates' were not coming down. The 0.50 point reductions are for the EBS two-year fixed rate product and the Haven three-year fixed rate product. Both Haven and EBS are also reducing all other non-green fixed rates by 0.20 percentage points. The new rates are available to new and existing customers from this Thursday. The reductions are in line with the falling interest rate environment and AIB's commitment to delivering value for customers, particularly those whose homes don't have a Building Energy Rating of B3 or higher, AIB Group said. The reductions will also help customers coming to the end of their fixed term, as they roll off historically lower rates into an environment where rates are now higher, it said. Customers who are switching their mortgage to EBS and Haven and meet the criteria will also benefit from the extension of the 'Cashback' and 'Switcher' offers to the end of December 2026 on certain products. The EBS Back in Cash offers give 2pc of the value of a mortgage upfront, plus 1pc after five years. There is also an offer of €3,000 in cash back from EBS on its green mortgage. Haven has a €5,000 cashback offer for new borrowers, and a €3,000 cash offer for switchers. Managing director of EBS and Haven director Paul Butler said: 'AIB Group, through AIB, EBS and Haven, believes it's critical we offer a wide variety of choice, value and convenience for customers seeking to buy their home, or switch their mortgage.' Mr Butler said a monthly repayment on a new €300,000 EBS two-year fixed rate mortgage, over a 25 year term, will be €1,566.99. The previous monthly repayment would have been €1,650.52, representing a saving of €83.53 per month, or €1,002.36 a year. A monthly repayment on a new €300,000 Haven three-year non-green fixed rate mortgage over a 25-year term will be €1,542.39. The previous monthly repayment would have been €1,625.21, representing a saving of €82.82 per month, or €993.84 annually. Michael Dowling of Irish Mortgage Brokers said last October AIB announced significant rate reductions to its 'green rates' making them the cheapest in the market. However, these reductions did not apply to EBS or Haven mortgage customers, despite the fact that both banks are 100pc owned by AIB. He said the 0.50 percentage points reduction only applies to the two-year fixed option with EBS and the three-year fixed option with Haven. 'The other non-green rates for AIB, EBS and Haven remain expensive compared to what competitors are offering,' Mr Dowling said. 'Extraordinarily, nine months later, there are no rate reductions to the 'green' rates from EBS and Haven.' Mr Dowling questioned why AIB 'discriminates' in the rate offering from the three entities within the group.


Irish Examiner
2 hours ago
- Irish Examiner
Irish biotech Ovagen believes study can 'transform' global vaccine manufacture
Groundbreaking results achieved by Irish biotech Ovagen Group could "transform the economics of global vaccine manufacturing", the company said on Wednesday. The company carried out its breakthrough study into yellow fever virus yield. Conducted at the UK's Pirbright Institute, the comparative study showed that Ovagen's Germ Free embryonated chicken eggs delivered up to 7,600 doses of yellow fever virus per egg compared to just 422 doses per egg using current industry standards. Speaking about the results of the study, Dr. Catherine Caulfield, CEO of Ovagen said: "What we have developed isn't incremental, it's a complete rethink of the vaccine manufacturing process," said Ovagen chief executive Dr Catherine Caulfield. "Our germ free egg platform eliminates bacterial contamination and reduces the need for antibiotics in vaccine production, while delivering significantly higher viral yield. "This is high-impact science with high-value commercial outcomes.' The comparative study showed that Ovagen's Germ Free embryonated chicken eggs delivered up to 7,600 doses of yellow fever virus 17D per egg compared to just 422 doses per Specified Pathogen-Free (SPF) Egg using current industry standards. With a current global shortfall of 60m yellow fever vaccines per year, Ovagen's technology can help scale up production of yellow fever vaccine production by reducing reliance on key raw material inputs such as SPF eggs, antibiotics, and downstream processing resources. More than 140,000 eggs would be required to satisfy the current global shortfall using current industry standards compared with just 7,894 eggs using Ovagen's technology. The improved yield also dramatically reduces the volume of antibiotics typically required in conventional egg-based manufacturing, helping to mitigate risks associated with antimicrobial resistance and lowering overall production costs. Based in Co Mayo, Ovegen has been supported over €21m in funding from Enterprise Ireland, private investors, promoters funds, venture capital, and the European Innovation Council. Ovagen operates from a purpose-built state-of-the-art facility and has successfully completed pilot trials with major vaccine manufacturers. 'Enterprise Ireland is proud to support Ovagen as they continue to scale their innovation and ambition. Their germ-free egg technology shows real potential to drive greater efficiency in vaccine manufacturing, and it's encouraging to see this level of innovation emerging from the West of Ireland. Ovagen's progress highlights the strength of Ireland's biotech sector and the impact that Irish companies can have on global health challenges," said Enterprise Ireland head of industrial and life sciences Tom Cusack.


Irish Independent
3 hours ago
- Irish Independent
Cork-based accounting firm to create 400 jobs as revenues sore
Ifac has four offices across the county in Bandon, Blarney, Mallow and Skibbereen, and is celebrating 50 years in operation this year. The firm has 30 offices scattered across Ireland, supporting over 30,000 clients. Through their services, they support 18,000 producers, 3,000 clients in the agri-food sector, and 7,000 SMEs with a full range of professional services, including accounting, tax, audit, corporate finance, consultancy, corporate recovery, payroll, financial planning, company secretarial, and business valuations. With revenues expected to hit €50 million, Ifac has transformed from its humble beginnings to become a top ten accountancy and advisory firm. The firm began as a specialist advisor to Irish farmers and has seen remarkable growth, from undergoing a successful rebrand in 2018 to expanding its services in farming, food, agri-business, the SME space, tax, and audit, thereby meeting and exceeding client needs. Founding chair Donal Cashman said the firm is investing in the communities they operate in. 'While the firm will continue to respect its heritage, it will continue to grow with Irish farmers and producers, alongside expanding into new markets. 'Its focus today is very much on continuous improvement, most recently marked by the launch of a new specialist team for mid to large SMEs. 'And as Ifac enters its next chapter, its mission remains unchanged: to help clients succeed on the farm, in business, and beyond,' Mr Cashman said.